EHS
EHS

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients




Researchers conducted a Phase II randomized placebo-controlled, double-blinded trial between July 8, 2020, and March 23. 2021.

Source link

EHS
Back to top button